Neogenomics plunges as BioReference Labs makes another acquisition

While correlation doesn't necessarily imply causation, it's probably worth noting that today's action in shares of Neogenomics (NEO -8.4%) mirrors the stock's dismal performance from last Tuesday.

The connection: Peer BioReference Laboratories (BRLI +2.5%) announced "strategic acquisitions" both today and on August 13.

From other sites
Comments (3)
  • 20 Slots
    , contributor
    Comments (64) | Send Message
    spell this out for me...why is one related to the other?
    21 Aug 2013, 04:18 PM Reply Like
  • ChrisForte
    , contributor
    Comments (216) | Send Message
    I thought merger activity in this niche industry would be good for NEO, especially since it's quite small and long been viewed as a potential acquisition target. The daily price is quite volatile and today's volume was fairly low, so I'm not sure about using the word 'plunge'. I'm open to other's opinions on this company.
    21 Aug 2013, 06:36 PM Reply Like
  • molechaser
    , contributor
    Comments (10) | Send Message


    21 Aug 2013, 06:46 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs